1. Home
  2. Labeler Index
  3. Cycle Pharmaceuticals Ltd.
  4. 70709-085
  5. NDC Package Code: 70709-085-10 Ormalvi

NDC Package 70709-085-10 Ormalvi

Dichlorphenamide Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70709-085-10
Package Description:
100 TABLET in 1 BOTTLE
Product Code:
70709-085
Proprietary Name:
Ormalvi
Non-Proprietary Name:
Dichlorphenamide
Substance Name:
Dichlorphenamide
Usage Information:
This medication is used to treat a certain inherited condition that causes attacks of muscle weakness or loss of muscle movement that come and go (primary periodic paralysis). Dichlorphenamide belongs to a class of drugs known as carbonic anhydrase inhibitors. It is not known how it works for this condition, but it can decrease the number of attacks of muscle weakness.
11-Digit NDC Billing Format:
70709008510
NDC to RxNorm Crosswalk:
  • RxCUI: 197594 - dichlorphenamide 50 MG Oral Tablet
  • RxCUI: 2677447 - ORMALVI 50 MG Oral Tablet
  • RxCUI: 2677447 - dichlorphenamide 50 MG Oral Tablet [Ormalvi]
  • RxCUI: 2677447 - Ormalvi 50 MG Oral Tablet
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Cycle Pharmaceuticals Ltd.
    Dosage Form:
    Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • DICHLORPHENAMIDE 50 mg/1
    • Pharmacologic Class(es):
  • Carbonic Anhydrase Inhibitor - [EPC] (Established Pharmacologic Class)
  • Carbonic Anhydrase Inhibitors - [MoA] (Mechanism of Action)
  • Sulfonamides - [CS]
    • Sample Package:
    No
    FDA Application Number:
    ANDA215924
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    03-15-2024
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 70709-085-10?

    The NDC Packaged Code 70709-085-10 is assigned to a package of 100 tablet in 1 bottle of Ormalvi, a human prescription drug labeled by Cycle Pharmaceuticals Ltd.. The product's dosage form is tablet and is administered via oral form.

    Is NDC 70709-085 included in the NDC Directory?

    Yes, Ormalvi with product code 70709-085 is active and included in the NDC Directory. The product was first marketed by Cycle Pharmaceuticals Ltd. on March 15, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 70709-085-10?

    The 11-digit format is 70709008510. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-270709-085-105-4-270709-0085-10